Gyre Therapeutics (GYRE) Change in Receivables (2013 - 2026)
Gyre Therapeutics (GYRE) posted Change in Receivables of $4.47 million for Q2 2026, up 5.4% from $4.24 million a year earlier.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Change in Receivables (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Receivables at Gyre Therapeutics was $1.74 million, down 71.5% year-over-year; for FY2025, it came in at $10.81 million, up 105.6% from FY2024.
- In prior years, Gyre Therapeutics' Change in Receivables was $5.26 million in FY2024, -$285,000 in FY2023, -$1.62 million in FY2022 and -$1.5 million in FY2021.
- Quarterly Change in Receivables has run from a low of -$8.57 million in Q1 2026 to a high of $4.83 million in Q4 2025 over five years.
- According to Business Quant data, Change in Receivables for the three prior quarters was -$8.57 million (Q1 2026), $4.83 million (Q4 2025) and $1.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 4.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.47 Mn |
| Mar 31, 2026 | -8.57 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 4.24 Mn |
| Mar 31, 2025 | 722,000.00 |
| Dec 31, 2024 | 1.15 Mn |
| Jun 30, 2022 | -564,000.00 |
| Mar 31, 2022 | -1.05 Mn |
| Dec 31, 2021 | 704,000.00 |
| Sep 30, 2021 | -857,000.00 |
| Jun 30, 2021 | 965,000.00 |
| Mar 31, 2021 | -2.31 Mn |
| Dec 31, 2020 | 1.76 Mn |
| Sep 30, 2020 | -433,000.00 |
| Jun 30, 2020 | 622,000.00 |
| Mar 31, 2020 | -13.63 Mn |
| Dec 31, 2017 | -27,000.00 |
| Sep 30, 2017 | -83,000.00 |
| Jun 30, 2017 | -93,000.00 |
API Access
Gyre Therapeutics Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();